000 01325 a2200397 4500
005 20250511182129.0
264 0 _c19920916
008 199209s 0 0 eng d
022 _a0301-0147
024 7 _a10.1159/000216296
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeuleman, D G
245 0 0 _aOrgaran (Org 10172): its pharmacological profile in experimental models.
_h[electronic resource]
260 _bHaemostasis
_c1992
300 _a58-65 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCarbohydrate Sequence
650 0 4 _aChondroitin Sulfates
650 0 4 _aDermatan Sulfate
650 0 4 _aFactor Xa Inhibitors
650 0 4 _aFibrinolytic Agents
_xpharmacology
650 0 4 _aGlycosaminoglycans
_xpharmacology
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHeparinoids
_xpharmacology
650 0 4 _aHeparitin Sulfate
650 0 4 _aMolecular Sequence Data
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _aThrombin
_xantagonists & inhibitors
650 0 4 _aThrombolytic Therapy
650 0 4 _aThrombosis
_xdrug therapy
773 0 _tHaemostasis
_gvol. 22
_gno. 2
_gp. 58-65
856 4 0 _uhttps://doi.org/10.1159/000216296
_zAvailable from publisher's website
999 _c1386459
_d1386459